Latest News

Sanofi reports positive results on multiple sclerosis drug licensed from Principia

The French drug giant Sanofi on Thursday reported positive results in a study of its new pill to treat multiple sclerosis.

The drug, which Sanofi licensed from South San Francisco-based Principia Biopharma in 2007, “significantly reduced disease activity associated with multiple sclerosis as measured by magnetic resonance imaging,” the company said in a statement. Full data on the drug, called SAR442168, are not being made available yet, but will be presented at a later medical meeting.

Read the rest…

Source link

Related posts

Halo Announces Completion of the Previously Announced Acquisition of Precisa Medical Instruments Corp. and Concurrent Private Placement


Blood pressure monitoring could become as easy as taking a video selfie in future


Diversifying the Health Workforce for an Equitable Future


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy